Eagle Pharmaceuticals Inc Quick Ratio (EGRX) starting from the second quarter 2023 to second quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Eagle Pharmaceuticals inc   (NASDAQ: EGRX)

Eagle Pharmaceuticals Inc 's Quick Ratio

EGRX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2023, Quick Ratio deteriorated to 0.18 below Eagle Pharmaceuticals Inc 's average Quick Ratio.

Within Major Pharmaceutical Preparations industry 535 other companies have achieved higher Quick Ratio than Eagle Pharmaceuticals Inc in second quarter 2023. While Quick Ratio total ranking in the second quarter 2023 has deteriorated compared to the prior quarter from 3704 to 3992.

Explain Quick Ratio?
How much Cash & cash equivalents EGRX´s has?
What are EGRX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EGRX Quick Ratio (Jun 30 2023)
Q2		 (Mar 31 2023)
Q1		 (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2
Y / Y Current Liabilities Change -20.5 % -3.77 % 74.55 % 151.55 % 143.96 %
Y / Y Cash & cash equivalent Change -58.01 % -68.5 % -43.35 % -84.58 % -66.37 %
Quick Ratio MRQ 0.18 0.22 0.43 0.13 0.34
EGRX's Total Ranking # 3992 # 3704 # 2797 # 3923 # 3227
Seq. Current Liabilities Change -11.43 % -24.66 % 6.56 % 11.81 % 7.2 %
Seq. Cash & cash equivalent Change -29.88 % -60.42 % 259.6 % -57.92 % -47.41 %



Quick Ratio second quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 536
Healthcare Sector # 1040
Overall Market # 3992


Quick Ratio Statistics
High Average Low
4.29 2.06 0.13
(Mar 31 2015)   (Sep 30 2022)




Financial Statements
Eagle Pharmaceuticals Inc 's Current Liabilities $ 87 Millions Visit EGRX's Balance sheet
Eagle Pharmaceuticals Inc 's Cash & cash equivalent $ 15 Millions Visit EGRX's Balance sheet
Source of EGRX's Sales Visit EGRX's Sales by Geography


Cumulative Eagle Pharmaceuticals Inc 's Quick Ratio

EGRX's Quick Ratio for the trailling 12 Months

EGRX Quick Ratio

 (Jun 30 2023)
12 Months		 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth 30.8 % 70.35 % 120.71 % 134.94 % 95.85 %
Y / Y Cash & cash equivalent TTM Growth -64.43 % -65.61 % -57.02 % -47.43 % -25.39 %
Quick Ratio TTM 0.25 0.28 0.38 0.54 0.91
Total Ranking TTM # 3020 # 4235 # 4214 # 4191 # 4124
Seq. Current Liabilities TTM Growth -4.87 % -0.83 % 13.63 % 22.01 % 23.89 %
Seq. Cash & cash equivalent TTM Growth -16.42 % -26.94 % -19.32 % -27.8 % -19.21 %

Quick ratio ranking by company, industry and sector >> Back to EGRX Financial Strength Comparisons >> Go to Compare EGRX Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in EGRX's Current Liabilities to $86.63 millions, cumulative Quick Ratio to 0.25 below the EGRX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 504 other companies have achieved higher Quick Ratio than Eagle Pharmaceuticals Inc . While Quick Ratio overall ranking has improved so far to 3020, from total ranking during the twelve months ending first quarter 2023 at 4235.

Explain Quick Ratio?
How much Cash & cash equivalents EGRX´s has?
What are EGRX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 505
Healthcare Sector # 983
Within the Market # 3020


trailing twelve months Quick Ratio Statistics
High Average Low
2.87 1.83 0.26
(March 31, 2016)   (Jun 30 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2023, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2023 MRQ Cash & cash equivalentJun 30 2023 MRQ Current Liabilities
Lifecore Biomedical Inc   0.49 $ 19.091  Millions$ 39.289  Millions
Opko Health Inc   0.48 $ 108.108  Millions$ 226.450  Millions
Galapagos Nv  0.46 $ 222.709  Millions$ 479.610  Millions
Camp4 Therapeutics Corporation  0.45 $ 34.960  Millions$ 77.286  Millions
Biophytis Sa  0.45 $ 6.235  Millions$ 13.849  Millions
Timber Pharmaceuticals Inc   0.45 $ 2.520  Millions$ 5.624  Millions
Intercure Ltd   0.45 $ 27.907  Millions$ 62.322  Millions
Aspire Biopharma Holdings Inc   0.44 $ 0.125  Millions$ 0.284  Millions
Optinose Inc   0.43 $ 71.311  Millions$ 164.299  Millions
Bristol myers Squibb Company  0.43 $ 8,730.000  Millions$ 20,150.000  Millions
Novartis Ag  0.43 $ 11,233.000  Millions$ 26,390.000  Millions
The Greater Cannabis Company Inc   0.42 $ 0.241  Millions$ 0.572  Millions
Elanco Animal Health Incorporated  0.39 $ 367.000  Millions$ 952.000  Millions
Heron Therapeutics Inc   0.38 $ 33.244  Millions$ 86.722  Millions
Gridai Technologies Corp  0.38 $ 1.236  Millions$ 3.261  Millions
Prestige Consumer Healthcare Inc   0.37 $ 54.580  Millions$ 147.271  Millions
Bausch Health Companies Inc   0.35 $ 579.000  Millions$ 1,677.000  Millions
Nls Pharmaceutics Ltd  0.34 $ 1.651  Millions$ 4.911  Millions
Biolinerx Ltd   0.33 $ 10.104  Millions$ 30.852  Millions
Aytu Biopharma Inc  0.32 $ 22.985  Millions$ 71.963  Millions
Innovation Pharmaceuticals Inc   0.32 $ 1.596  Millions$ 5.021  Millions
Redhill Biopharma Ltd   0.31 $ 6.996  Millions$ 22.354  Millions
Thorne Healthtech Inc   0.30 $ 17.094  Millions$ 56.245  Millions
Harrow Inc   0.30 $ 6.917  Millions$ 23.011  Millions
Lftd Partners Inc   0.30 $ 2.085  Millions$ 6.986  Millions
Jaguar Health Inc   0.30 $ 8.627  Millions$ 29.003  Millions
International Stem Cell Corporation  0.29 $ 1.382  Millions$ 4.744  Millions
Cv Sciences Inc   0.29 $ 1.690  Millions$ 5.849  Millions
Avalo Therapeutics Inc   0.28 $ 6.322  Millions$ 22.454  Millions
Merck and Co Inc   0.27 $ 6,378.000  Millions$ 23,394.000  Millions

Date modified: 2026-09-08T15:11:01+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.